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Abstract
Background: The comparison of organ transcriptomes is an important strategy for understanding
gene functions. In the present study, we attempted to identify lung-prominent genes by comparing
the normal transcriptomes of rat lung, heart, kidney, liver, spleen, and brain. To increase the
efficiency and reproducibility, we first developed a novel parallel hybridization system, in which 6
samples could be hybridized onto a single slide at the same time.
Results: We identified the genes prominently expressed in the lung (147) or co-expressed in lung-
heart (23), lung-liver (37), lung-spleen (203), and lung-kidney (98). The known functions of the lung-
prominent genes mainly fell into 5 categories: ligand binding, signal transducer, cell communication,
development, and metabolism. Real-time PCR confirmed 13 lung-prominent genes, including 5
genes that have not been investigated in the lung, vitamin D-dependent calcium binding protein
(Calb3), mitogen activated protein kinase 13 (Mapk13), solute carrier family 29 transporters,
member 1 (Slc29a1), corticotropin releasing hormone receptor (Crhr1), and lipocalin 2 (Lcn2).
Conclusion: The lung-prominent genes identified in this study may provide an important clue for
further investigation of pulmonary functions.
Background
With the completion of genome projects of human and
other model species, functional studies on a genomic
scale are coming to a frontier. The investigation of tran-
scriptome reveals gene expression of organs and cells from
normal and diseased animals and humans. By comparing
transcriptomes of multiple organs, physiological func-
tions in different organs can be further explored. Identify-
ing the genes expressed prominently in the lung may
reveal its unique physiological functions in the respiratory
system.
The expression of some individual genes in the lung and
other organs may be found in literature and public data-
bases. In literature, newly discovered genes have been
tested in various organs at the mRNA level with Northern
blotting and RT-PCR and at the protein level with Western
blotting. In public databases, gene expression are com-
piled from literature, cDNA library (e.g. UniGene) and
high throughput tools such as serial analysis gene expres-
sion (SAGE) and DNA microarray (e.g., GEO) [1]. Several
studies using DNA microarray have been reported for pro-
filing differential gene expression among normal human
and mouse organs, but very little information is available
for the rat [2-6].
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ential expression of thousands of genes between two sam-
ples [7]. For three or more samples, a reference or loop
design has to be employed to adapt dual color hybridiza-
tion [8,9]. In the reference design, several samples are
hybridized onto different slides separately with a com-
mon reference, which is prepared by pooling all the sam-
ples or using genomic DNA [10]. In the loop design,
samples are paired in a loop pattern for hybridization and
each sample is hybridized twice. However, the efficiency
and reproducibility of both designs are poor for the iden-
tification of organ-prominent genes. Only two samples
are hybridized on one slide, and the hybridization on dif-
ferent slides is known to have high variations due to slide
printing and hybridization conditions [7]. For instance,
there are 15 pair-wise combinations among 6 distinct
organs. Consequently, 15 co-hybridizations between sam-
ples are required for a single replication and 60 slides for
an experiment with 4 biological replications.
To eliminate these problems, we developed a parallel
hybridization system in which 6 samples can be hybrid-
ized onto one single slide. This technique simplifies the
investigation of multiple samples, reduces experimental
errors and improves experimental efficiency. Using this
system, we investigated lung-prominent genes by compar-
ing gene expression profiles among rat lung, heart, kid-
ney, liver, spleen, and brain. The lung-prominent genes
identified in the present study may provide a clue for fur-
ther exploration of pulmonary functions.
Results
Reproducibility and efficiency of parallel hybridization
Our parallel hybridization system consists of three identi-
cal blocks: A, B, and C, on a single slide (Table 1). Each
block contains ~10,000 50-mer oligonucleotides (6,221
known rat genes, 3,594 rat ESTs, and 169 Arabidopsis neg-
ative controls). Six labeled cDNA samples (3 Cy3 and 3
Alexa 647) were combined into 3 green-red pairs and
hybridized onto each block of one slide. During the
hybridization step, the blocks were separated by thermo-
static tapes. The latter was removed during the washing
and scanning steps. To examine whether there was cross-
contamination among blocks, blocks A and C on the same
slide were hybridized simultaneously for 3 days with
Alexa 647-labeled lung cDNA. No signals were detected in
block B (data not shown), indicating no cross contamina-
tions among blocks.
Self-self hybridizations were performed on three slides to
assess the reproducibility of hybridizations using Cy3-
and Alexa 647-labeled lung cDNA samples. We observed
the highest correlation coefficient between two samples
co-hybridized in one block (within-block group, Fig. 1A),
and the lowest one between two samples hybridized in
two different blocks on two separate slides (among-slide
group, Fig. 1C). The within-slide group (two samples in
two distinct blocks on one slide, Fig. 1B) possessed a sig-
nificantly higher reproducibility than the among-slide
group, but lower than the within-block group (Fig. 1D, p
< 0.01). The lower reproducibility of the among-slide
group may be due to the experimental variations among
slides, such as hybridization temperature fluctuation,
washing, and scanning. These conditions were identical
for the within-block and within-slide groups, in which
samples were hybridized in a single slide.
Next, we investigated the relative gene expression levels in
6 rat organs: lung, heart, kidney, brain, spleen, and liver.
The hybridization of each organ was repeated 20 times: 4
biological replications (rats), each with 5 technical repli-
cations (slides). Six samples from each of four rats were
split into 5 aliquots for hybridization on 5 slides. The
labeling dyes, the sample pairing, and the hybridization
blocks on a slide were randomly assigned for each biolog-
ical replication. This minimized the variations among
biological and technical replications, including animals,
fluorescence dyes, sample combinations, blocks on a
slide, slides, and experimental conditions (Table 1). Sta-
tistically, each slide was a random block containing 6
samples. There were 60 sample-sample hybridizations
performed on 20 slides (60 Alexa 647-cDNA and 60 Cy3-
Table 1: Slide layout and hybridization design
Slide Block A Block B Block C
Green Red Green Red Green Red
1 Lung Heart Liver Brain Kidney Spleen
2 Heart Kidney Liver Lung Spleen Brain
3 Kidney Liver Lung Brain Spleen Heart
4 Heart Brain Kidney Lung Liver Spleen
5 Heart Liver Lung Spleen Brain Kidney
The array has three identical blocks, A, B, and C; each containing 9,984 spots representing 6,221 known rat genes, 3,594 ESTs, and 169 Arabidopsis 
negative controls. The three blocks are separated with thermal plastic rings. Three paired Cy3-(green) and Alexa 647 (red)-labeled cDNA samples 
were hybridized onto three blocks, A, B, and C of slide 1–5. Dye and sample assignments are random for each slide. Five slides represent technical 
replications.Page 2 of 14
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Reproducibility of hybridizationsFigure 1
Reproducibility of hybridizations. (A-C):typical scatter plots of self-self hybridization of lung cDNAs between two chan-
nels within a block (within-block, panel A), two different blocks in one slide (within-slide, panel B), and among slides (among-
slide, panel C), respectively. The cDNAs from an identical lung tissue were labeled with Cy3 or Alexa 647, and hybridized to 
each block of the slides. The numbers on x- and y-axis were background-subtracted fluorescence intensities of each spot with 
log2 transformation. (D) A comparison of correlation coefficients from replicated hybridizations. The results were expressed 
as means ± SE. *P < 0.01 v.s. among-slide; #P < 0.01 v.s. within-slide. (E) Comparison of accumulated errors between within-
slide and among-slide groups. For the within-slide group, the log ratios were from parallel hybridization on a single slide. For 
the among-slides, the log ratios were from different slides. The accumulated errors were calculated as described in Materials 
and Methods.
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BMC Genomics 2006, 7:47 http://www.biomedcentral.com/1471-2164/7/47cDNAs) in this experiment. To achieve similar statistical
results, a traditional reference design requires 120 slides
for co-hybridizations of sample and reference. Alterna-
tively, in a loop design, 60 slides are required for co-
hybridization of sample-sample.
The difference of fluorescence intensity between the paral-
lel hybridization and traditional dual-color hybridization
was evaluated. We first compared the difference of log
ratios between the traditional and parallel hybridization
systems by SAM [11]. The samples of lung and heart were
used as an example. The log ratios of fluorescence inten-
sity between lung and heart were normalized with the
print-tip based LOWESS [7]. The traditional log ratios
were from 4 slides, in which lung and heart were paired
and co-hybridized onto the same block of each slide. The
parallel log ratios were from 4 other slides, in which lung
and heart were hybridized onto two different blocks of
each slide. The 2-class SAM test identified no genes that
showed a significant difference between the traditional
co-hybridization group and the parallel hybridization
group (false discovery ratio<0.047, q-value>0.05). Other
organ pairs showed similar results. These results demon-
strated that the log ratios of two samples from two differ-
ent blocks in the parallel hybridization were not
significantly different from that of the traditional two
sample co-hybridization. Consequently, any two of the
six samples hybridized onto one slide in the parallel
hybridization can be directly compared as if these samples
were pair-wise combined and co-hybridized onto one tra-
ditional slide.
We also tested the accumulated error of the log2 ratios
among 6 organs. In a traditional loop design, the sum of
log ratios along the loop should be zero, but frequently
fluctuating. Therefore, the square sum of log ratios can be
adapted to assess the accumulated error of each gene or
the data fluctuation in one experiment. We selected one
block from each of the six different slides and simulated
the traditional loop design. The 6 blocks formed a loop as
if they were 6 traditional co-hybridization slides. In
another group, a loop was formed from a single parallel
hybridization slide. The slides for both groups were ran-
domly selected. The accumulated errors were calculated as
described in the Materials and Methods, followed by being
sorted ascendingly, and plotted against ranked genes. We
found that 21% of the genes showed an accumulated error
of >5 in the traditional hybridization group, but only 4%
in the parallel hybridization group (Fig. 1E). A paired t-
test of the accumulated errors between the two groups
revealed that the fluctuation of the traditional co-hybridi-
zation was significantly higher than that of the parallel
hybridization (p < 0.05).
Prominent genes expressed in the lung
Lung-prominent genes were identified through quality fil-
ter, statistics filter, and image confirmation. Several steps
of data analysis were followed (see Materials and Methods
for details): (i) After hybridization, we first checked the
qualities of whole hybridization images and excluded the
images from poor slides (one out of 20 slides was dis-
carded); (ii) We filtered 2,829 low quality spots based on
a mean quality index of <1 as our quality filter; (iii) Statis-
tics test using SAM analysis revealed that the expression
levels of 3,576 genes were significantly different among 6
organs (false-positive ratio <5%, and median false discov-
ery ratio <0.05); (iv) In order to identify organ-prominent
or co-expressed genes, the genes passed SAM test were fur-
ther analyzed by multiple comparisons using Turkey's
honestly significant difference (HSD) tests at an overall
confidence level of 95%. Organ-prominent genes are
defined as genes that are expressed significantly higher in
one particular organ than any other organs (P < 0.05).
Similarly, co-expressed genes are the genes that are
expressed significantly higher in two organs than any
other 4 organs (P < 0.05). There were some duplicated
genes in single and two organ-prominent groups. The
duplicated genes with a lower OSI were filtered. The
duplication was due to the HSD-based multiple compari-
sons. For instance, endothelial cell growth factor protein
precursor (VEGF, Genbank ID: NM_031836) was
expressed significantly higher in the lung than other
organs (p < 0.05, OSI for lung = 0.975). This gene was also
co-expressed significantly higher in the lung and the liver
than in other organs (p < 0.05, OSI for lung and heart =
0.778). In this case, we thus deleted this gene from the
lung-liver group; (v) Finally, we further verified the genes
identified above by directly comparing the results with
spot images in a spreadsheet using the RealSpot software
[12]. The visually inconsistent genes with spot images
were filtered. The final genes were summarized in Fig. 2
and the hot maps of these genes were shown in Fig. 3. The
liver showed the highest number of prominent genes (306
genes) and spleen the lowest (75 genes). The numbers of
other organ-prominent genes were brain (218), kidney
(163), lung (147), and heart (95). The lung had a high
number of co-expressed genes with other organs: lung-
spleen (203), lung-heart (23), lung-liver (37), lung-kid-
ney (98), and lung-brain (10). The kidney also had a high
number of co-expressed genes, kidney-liver (151) and kid-
ney-brain (19). A list of all the organ-prominent genes is
given in Additional file 1 (Supplementary Table E1, the
excel format to show gene expression data) and Addi-
tional files 2 and 3 (Supplementary Table E2A and E2B,
the PDF format to show spot images).
The prominent genes for one or two organs were further
classified into 4 functional categories: function unclear,
cellular location, molecular function, and biological proc-Page 4 of 14
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base http://rgd.mcw.edu and Gene Ontology http://
www.geneontology.org. The main functional categories of
prominent genes were summarized in Additional file 4
(Supplementary Table E3) for one organ and in Addi-
tional file 5 (Supplementary Table E4) for two organs. The
functions of the lung-prominent genes include ligand
binding, signal transducer, cell communication, develop-
ment, and metabolism. The cellular location was omitted
since only a few genes were documented at the sub-cellu-
lar level. It is worthy to note that the functions of 60% or
more genes we identified remain unclear in the present
time.
Real-time PCR verification
Based on our research interests, we focused on lung-prom-
inent genes for real-time PCR verification. We selected
genes based on both mRNA abundance (signal intensity)
and organ specificity index (OSI). OSI was defined as the
correlation coefficient of expression levels between an
interested gene and a putative gene that had 100% specif-
icity (see Materials and Methods). The known lung marker
genes have high OSIs, e.g. T1α, 0.996; SP-A, 0.993; SP-D,
0.993; SP-B, 0.933; CCSP, 0.972; and SP-C, 0.912 (Addi-
tional file 1). We chose 13 genes, which ranked in the top
30% in signal intensity (high expression level) and the top
10% in OSI (high specificity). In addition, we selected 3
genes that ranked below 30% in signal intensity (low
expression level). Real-time PCR verified 13 genes that
were expressed significantly higher in the lung than in
other organs (Fig. 4). These genes include BD-2, K19,
Calb3, SP-D, ICAM-1, Mapk13, Crhr1, Slc29a1, Ager,
Slc34a2, Lcn2, Ddr2, and Mg50. Furthermore, the expres-
sion level for most of the genes in the lung was 10 times
or more greater than that in other organs. The expression
pattern of these genes was consistent with DNA microar-
ray signals (Additional file 6). Three genes, Nup155,
MMP9 and Sp4, did not show a significantly higher
mRNA abundance in the lung when compared to other
organs under our experiment conditions. This is due to
high variations between samples.
Discussion
In the current study, we developed a parallel hybridiza-
tion, in which 6 samples can be hybridized onto one sin-
gle slide. This method provides higher reproducibility and
efficiency than the standard co-hybridization, and should
be suitable for experiments investigating multiple biolog-
ical samples. Using this system, we identified genes prom-
inently expressed in one or two organs of the rat lung,
heart, kidney, liver, spleen, and brain. Thirteen out of 16
selected lung-prominent genes were verified by real-time
PCR. The genes identified in present study may be useful
for further functional investigation in the lung or other
organs.
The organ-prominent genes we identified were directly
based on statistical comparisons of normalized spot sig-
nals. These genes were further ranked by organ specificity
index (OSI). The "standard" DNA microarray data process
extracts fluorescence intensities of both channels from
hybridization images, and calculates and normalizes
ratios for further statistical analysis. Our method is differ-
ent from the "standard" analysis in several ways: (i) we
linearly transformed all of the spot signals from each
channel of hybridization images into a 0–1,000 scale,
which made different channels and slides comparable.
Unlike the ratio normalization, we retained relative
expression levels in each channel. This is especially useful
for multiple sample comparisons; (ii) Gene classification
was based on multiple comparison. Differentially
expressed genes among the 6 organs were identified from
SAM test, followed by multiple comparison using Tukey's
HSD; and (iii) we ranked the genes by organ specificity
index (OSI), higher OSI, more specific a gene in one or
two organs. In this investigation, we selected lung-promi-
nent genes for verification based on the combination of
OSI and normalized spot intensity. We chose the genes
ranked in the top 10% in OSI and the top 30% in spot
intensity, which ensures both the lung-specificity and the
gene expression level.
Summary of differentially expressed genes among 6 organsFigure 2
Summary of differentially expressed genes among 6 
organs. The number under an organ represents the genes 
that are expressed significantly higher in the respective organ 
compared to other organs (p < 0.05). Similarly, the number 
between any two organs represents the genes that are 
expressed significantly higher in the two organs compared to 
other organs (p < 0.05). Thicker lines highlight a larger 
number of the genes co-expressed in the respective two 
organs.
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Hot maps of Organ-prominent genesFigure 3
Hot maps of Organ-prominent genes. Left and right panels are the relative expression levels of genes differentially 
expressed in one and two organs, respectively. Each column represents 19 replicated hybridizations of each organ and each 
row shows the spot signals of the organ-prominent genes. The scale of normalized spot signals was indicated on the top of the 
graph. (A): lung: 166 genes; (B) heart: 100 genes; (C) kidney: 186 genes; (D) liver: 324 genes; (E) spleen: 88 genes; (F) brain: 225 
genes; (G) lung-heart: 47 genes; (H) lung-liver: 33 genes; (I) lung-spleen: 95 genes; (J) kidney-liver: 174 genes; (K) lung-kidney: 
21 genes; (E) kidney-brain: 21 genes.
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profiles in human and mouse [2-6]. Only one report was
done on rats with a focus on the brain using commercial
Affymetrix chips (7,000 known genes and 1,000 EST) [6].
In this data set, the lung and liver were not included and
only two replications for the spleen, heart, and kidney
were used. In comparison, 2,426 genes out of the 3,576
differential genes (current study, without image-filter)
were found to be common with the Walker's study [6].
The correlation coefficient of relative expression between
the two data sets was around 0.4 for heart, kidney, or
spleen. The low quantitative correlation may be due to the
differences between Affymetrix and our in-house microar-
ray platforms such as glass slide/silicon wafer, two/one
channel, and 50-mer oligonucleotide/25-mer oligonucle-
otide set. However, the two data sets showed a consistent
gene expression pattern among heart, kidney, and spleen,
when we manually compared differential expression of
the genes with top OSI for each pattern.
We also compared our dataset with the published datasets
from other species. In the Novartis GNF dataset, transcrip-
tomes of mouse organs were compared, each organ with
duplicated single channel hybridizations [5]. Of the 147
lung-specific genes in our dataset, 102 were found in the
mouse microarray dataset (totally 31,770 genes). Based
on OSI>0.75, calculated from their dataset, we found that
36 lung-prominent genes are common with our dataset.
Six of them were on the list of our 13 real-time PCR-veri-
fied lung-prominent genes, including Ager, K19, SP-D,
ICAM-1, Slc34a2, and Lcn2. Another verified gene,
MAPK13 was not in the 36 genes. Its signals were less than
50 in all of the mouse organs.
We further compared our dataset with available human
datasets. The dataset http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE2361 and http://
www.genome.rcast.u-tokyo.ac.jp/normal/ listed 43
human lung-specific genes. Many known lung-specific
Relative mRNA abundance of lung-prominent genes determined by relative real-time PCRFigure 4
Relative mRNA abundance of lung-prominent genes determined by relative real-time PCR. The mRNAs from six 
organs were reverse-transcribed to cDNA and quantified by relative real-time PCR. All of the genes were run on the same 
plate with 18S rRNA as an endogenous reference. The results were expressed as % of lung. Data shown are means ± S.E. (n = 
3 biological replications).The mRNA expression level of all the genes in the lung was significantly higher in other organs (P < 
0.05).
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list. Among 43 genes on the list, 18 genes were found in
our list of lung-prominent genes, including known lung-
specific genes, surfactant proteins, ager and a verified
gene, Slc34a2. Similarly, in another human tissue dataset
(PubmedID: 15774023), 50 lung-specific genes were
identified based on one human lung tissue hybridization.
Once again surfactant proteins and ager were not in list.
The only common gene between the list and our lung-
prominent genes was caveolin. Finally, when comparing
our rat dataset (10 K genes) and the Novartis GNF dataset
human (10 K genes) datasets, we found 368 common
genes between the datasets. Only 2 common genes,
MAPK13 and latent transforming growth factor beta bind-
ing protein 2 (LTBP2), appeared to be lung-prominent
based on the OSI. There were more common genes
between the rat and the mouse datasets than these
between the rat and the human datasets.
The published dataset was based on one or two hybridiza-
tion of normal lung tissue. Our lung-prominent genes
were based on 20 replicated DNA microarray hybridiza-
tions (4 biological and 5 technical replications). We
believe that our gene lists were statistically confident and
had a lower false-positive or false-negative genes.
The 13 lung-prominent genes we verified by real-time
PCR have various functions, including pulmonary
defenses, ion/solute transport, hormone receptor, differ-
entiation, oxidant response and tumorgenesis. Five of
them are defense genes. BD-2 (β-defensin 2) is a cationic
peptide with a broad-spectrum antimicrobial activity and
contributes to innate immunity in the lung [13]. It is
expressed in the airway epithelia [14]. BD-2 was increased
in the patients with inflammation and infections [15,16].
SP-D (surfactant protein D) is highly expressed in alveolar
epithelial type II cells and plays a pivotal role in cell
defense against microbes [17,18]. For instance, it has been
reported that SP-D inhibited the proliferation of bacteria
by increasing the permeability of the microbial cell mem-
brane. ICAM-1 (intercellular adhesion molecule 1) is a
cell adhesion molecule and a ligand for leukocyte adhe-
sion molecule LFA-1. ICAM-1 also participates in the
inflammatory response to lipopolysaccharide-induced
lung injury by interacting mainly with neutrophils [19].
Lipcocalin 2 (also known as α2u-globulin-related protein,
X13295) is a member of lipocalin protein family com-
posed of small secreted proteins that have the ability to
bind to small hydrophobic ligands [20]. Lipocalin 2
expression in the lung is markedly increased in acute lung
injury caused by diesel exhaust particles and lipopolysac-
charide [21]. Mapk13 (mitogen activated protein kinase
13) plays a role in stress and inflammatory responses via
the MAPK cascade signaling pathway. Mapk13 is predom-
inantly expressed in the lung although a small amount of
Mapk 13 is also present in kidney [22], which is consistent
with our results (Fig. 4).
Three of the identified lung prominent genes are ion/sol-
ute transporters. Calb3 (Calbindin 3), a vitamin D-
dependent Ca2+ binding protein, was previously studied
in the intestine, uterus, placenta, and lung epithelium
[23]. It is a Ca2+ transporter and regulates Ca2+ homeosta-
sis. Slc29a1 (solute carrier family 29 transporter, member
1) is an equilibrative nitrobenzylthioinosine-sensitive
nucleoside transporter (ENT1), which transports nucleo-
sides into or out of the cells in a Na+-independent manner
[24]. Northern blot analysis has shown that Slc29a1 is
highly expressed in the lung and testes [25]. It plays a role
in nucleotide biosynthesis and cellular signaling. Slc34a2
(solute carrier family 34 sodium phosphate, member 2) is
a sodium dependent phosphate transporter. It has been
shown that Slc34a2 was predominantly expressed in the
lung and in situ hybridization revealed that it is localized
in alveolar type II cells [26]. Slc34a2 provides inorganic
phosphate for the synthesis of lung surfactant.
Crhr1 (corticotropin releasing hormone receptor 1) is a
receptor that binds corticotropin-releasing hormone. The
mice null for the CRFR1 gene died within 48 hours after
birth because of a pronounced lung dysplasia [27]. Inter-
estingly, variation of Crhr1 was associated with improved
function in the asthma patients who were treated with
inhaled corticosteroids [28]. K19 (keratin 19) is expressed
in epithelial cells, involved in testicular differentiation
and lung cancer [29,30]. Ager (advanced glycosylation
end product-specific receptor) is a member of the immu-
noglobin superfamily and is involved in oxidant
response. It is specifically expressed in alveolar epithelial
type I cells [31]. Lung type I cells are squamous, covering
>90% of alveolar surface, and, thus, are easily damaged by
oxidants. Ager may protect lung type I cells from oxidative
injury.
The two lung-prominent genes with lower mRNA abun-
dance, Ddr2 and Mg50, may be involved in human
tumorgenesis http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&li
st_uids=15111304&query_hl=1, and the regulation of
collagen remodeling in the lung http://
www.ncbi.nlm.nih.gov/entrez/
query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&li
st_uids=11103812&query_hl=11.
The functions of 13 verified genes as well as some highly
abundant co-expressed genes in the lung and another
organ were summarized in Table 2. These co-expressed
genes were previously studied in the lung or another
organ. The most prominent genes expressed in the lung
were relevant to pulmonary protection, including oxidantPage 8 of 14
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and immune response. These genes also contribute to
organ construction such as lung veins, energy supply, and
epithelial tight junction. Some of these genes may be
important for cell proliferation, such as anp and nf2. Two
genes, anp and aqp5 may play a role in asthma and
edema, respectively. The function of cd37 is currently
unclear in any of the organs. Its prominent and specific
expression in the lung may imply its important role for
lung function. Cd37 may participate in cell proliferation
in the lung based on the studies from other members of
this gene family. Similarly, cathepsin Y may play a role of
surfactant protein processing or apoptosis considering its
endopeptidase activity in the spleen and the functions of
cathepsin D and H in the lung. These hypothesized func-
tions may serve as a starting point for further functional
studies in the respective organs.
The parallel hybridization system has several advantages
over the traditional two-color hybridization. First, in this
hybridization system 6 paired and dual-color labeled
samples were hybridized onto one slide and scanned
under identical conditions. The homogenous conditions
on one slide improved the reproducibility and decreased
the variation, especially accumulated experimental errors.
The latter is problematic in microarray experiments
involving a series of samples such as a time course study.
Second, any two of the six samples in a parallel hybridiza-
tion can be directly compared, whereas only two paired
samples can be directly compared in the traditional two-
color hybridization of a reference or loop design. This
increases the experimental efficiency and reduces the
number of slides and the amount of RNAs in a whole
experiment. In the parallel hybridization system, only one
slide is needed for six samples. In contrast, 6 slides are
required for a reference or loop design of six samples in
the traditional two-color co-hybridization. The RNA
amount is reduced to half that of the traditional hybridi-
zation. This is because each sample needs to hybridize
twice with neighboring samples in the loop design or
hybridize to a common reference consisting of all the
samples in the reference design. Multiple-color hybridiza-
tion on one slide could be developed for three or more
samples labeled with distinct fluorescence dyes. However,
the potential cross-talk among fluorescence dyes and the
need for multiple lasers of a scanner limit its application.
The organ-prominent genes in the current study were
identified from 6 organs. Some of them may be expressed
higher in other tissues outside the 6 organs we monitored.
Table 2: Gene functions in the lung and 2nd organ
Gene Function in lung 2nd organ (location) Function in 2nd organ
Ager Oxidant response (AEC I)*
ICAM-1 AEC-leukocyte adhesion (AEC)
K19 Cell differentiation (AEC)
SP-D, BD-2 Defense, surfactant (AEC II)
slc42a2 Surfactant synthesis? (AEC II)
Calb3 Ca2+ homeostasis
Mapk13 Inflammatory response
Slc29a1 Ion transporter?
Lcn2 Apoptosis?
Crhr1 Hormone receptor?
Ddr2 Collagen remodeling
Mg50 Tumor pathogenesis?
Tnni2, tni3 Lung veins [35] Heart Muscle contrast [36;37]
Cox6a2, Cox8h Energy supply? Heart Muscle energy supply [38] [39]
Anp Asthma? [40] Heart Proliferation control [41]
Aqp5 Edema? Liver Fluid homeostasis [42]
Ces3, gpt Injury and repair [43] [44] Liver Injury [45]
Cyp2615 Oxidantive stress [46] Liver Xenobiotic metabolism?
Cldn3 Epithelia barrier [47] Liver Paracellular permeability [48]
S100a18 Cell migration [49;50] Spleen Cell motility?
Iga, Igm [51] [52] Immune response Spleen Immune response
Cd37 [53] Proliferation? Spleen Proliferation?
Cathepsin Y Surfactant process? [54] [55] Spleen Endopeptidase [56;57]
Fas, Alp AEC II injury [58] Kidney Renal injury [59] [60]
Tpa66 Inflammatory [61] Kidney Anti-arterial thrombosis [62]
Nf2 [63] Tumor supression Kidney Tumor suppression
* AEC I and II: Alveolar epithelial type I and II cells. See the main text for more references.
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BMC Genomics 2006, 7:47 http://www.biomedcentral.com/1471-2164/7/47This limitation may be overcome by further improvement
of the parallel hybridization system. One possibility is to
include one common control organ (e.g. lung) in all of
the parallel hybridization slides. Although it reduces the
efficiency, the transcriptomes of more than 6 organs can
be directly compared. Another possibility is the potential
technical improvement of spot printing and sample
arrangement, which may result in more than 6 samples on
one parallel slide. In the present study, we printed 10 K rat
genes in triplicate on three blocks on one slide. Each block
contains 16 sub-arrays (4.5 × 4.5 mm) consisting of 625
genes. Therefore, 6 samples can be hybridized to 10 K
genes in this system. If we print 625 genes onto 48 sub-
arrays in replicate, 96 dual-color labeled samples can be
hybridized on one slide. Furthermore, if we increase the
printing resolution from 160 to 80 microns, we can print
2,500 spots on one sub-array. Consequently, 96 samples
can be hybridized to one slide containing 2,500 genes.
Another improvement may be the separation of the slide
regions. We used thermostatic tapes to divide 3 blocks,
which may not be appropriate for more samples. The
chambered coverslips of 24 or 48 wells such as Cul-
tureWell™ coverslip system or array of arrays glass wafer
[32] may be adapted for this purpose.
Methods
Microarray preparation
The DNA microarray slides used in this study were in-
house printed on epoxy-coated glass slides with 50-mer
aminated oligonucleotides, Pan Rat 10 K Oligonucleotide
Set (MWG Biotech Inc., High Point, NC). It contains
6,221 known rat genes, 3,594 rat ESTs, and 169 Arabidop-
sis negative controls. The oligonucleotides were sus-
pended in 3× SSC at 25 μM and printed on epoxy-coated
slides (CEL Associates, Pearland, Texas) with an Omni-
Grid 100 arrayer (GeneMachine, San Carlos, CA) per
manufacturer's instructions. Each oligonucleotide was
spotted in triplicate on three identical 18 × 18 mm blocks:
A, B, and C (Table 1). The total spots on one slide were
30,000 including 186 blank spots. The spot-spot distance
was 180 μm and the space between blocks was 4 mm. The
printed slides were incubated in 65% humidity overnight
at room temperature. The slides were then dried and
stored in room temperature. Prior to hybridization, the
slides were washed one time with 0.2% SDS, four times
with water, and dried by centrifugation. The 3 blocks on a
slide were separated by two 2 × 25 × 1 mm thermostatic
transparent tape stripes during the hybridization. The
stripes were removed after hybridization to wash and
scann slides.
Sample collection and hybridization
Six organs, the lung, heart, kidney, liver, spleen, and brain
of male Sprague-Dawley rats (200 g, Charles River Labo-
ratories, Inc., Wilmington, MA) were dissected. The
organs were briefly washed with deionized water and
immediately homogenized in 10 ml TRI reagents (Molec-
ular Research Center, Cincinnati, OH). Total RNA was
subsequently extracted according to the manufacturer's
protocol. RNA quality and quantity were assessed by spec-
trophotometer (NanoDrop Technologies, Inc, Rockland,
DE) and agarose gel electrophoresis. Total RNA samples
were aliquoted (20 μg each) for cDNA synthesis and 2-
step microarray hybridization with 3DNA 50 Expression
kit (Genisphere Inc., Hatfield, PA). Briefly, total RNA was
reverse-transcribed with Cy3- or Alexa 647-specific prim-
ers. The cDNA products were purified with the Microcom
YM-30 columns (Millipore, Billerica, MA) and mixed with
2× formamide hybridization buffer (50% formamide, 6×
SSC, 0.2% SDS). The DNA microarray slides were hybrid-
ized with the cDNA samples at 42°C for 48 hours. The
slides were washed and re-hybridized with Cy3- and Alexa
647-specific capture reagents at 42°C for 2 hours. In our
experiments, the concentration of purified cDNA samples
were normalized to 0.5 – 0.6 μg/μl before hybridization.
The cDNA aliquots from 6 organs of the same rat were
randomly paired and independently hybridized onto one
of 3 blocks on a glass slide. Each sample was repeated 20
times: 4 biological replications and 5 technical replica-
tions. The arrangement of samples, fluorescence dyes, and
blocks for one of the biological replications is shown in
Table 1. The other 3 biological replications were similarly
arranged in a style of random block design. Each hybrid-
ized slide was scanned twice by a laser confocal scanner,
ScanArray Express (PerkinElmer Life and Analytical Sci-
ences, Boston, MA). The first scanning was used for quan-
tification and performed with 90% laser power and
70~80% PMT so that about 5% spots were saturated. The
second scanning was used for spot alignment and was car-
ried out with 90% laser power and 95% PMT. Hybridiza-
tion images were analyzed with GenePix pro 4 (Axon
Instruments, Inc. Union City, CA).
Data analysis
Hybridization reproducibility
The reproducibility was assessed by Pearson correlation
coefficients of spot signals from self-self hybridizations.
The spot signals were background-subtracted fluorescence
intensity extracted from hybridization images by GenePix.
To estimate the variations among 6 paired organs, accu-
mulated errors of log ratios were calculated. The log ratios
between two samples were assessed from the respective
spot signals, normalized by local weighted scatter plot
smooth (LOWESS) based on print-tip. The accumulated
error of ratios of each gene was assessed as (1)
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ized log ratios between samples s1~s6, the 6 organs
arranged in a loop design. The e was calculated in 2
groups, within-slide group and among-slide group. The
log ratios of within-slide group were obtained from one
slide with 6 samples, and those of among-slide group
were from 6 slides comprised of a loop design for 6 sam-
ples.
Identification of lung-prominent genes
To identify differentially expressed genes among 6 organs,
we first globally normalized 16-bit mean fluorescence
intensity of each gene from original images using the soft-
ware RealSpot developed in our laboratory [12] (freely
available for download for academic usage, http://
www.lungmicroarray.org). The global normalization con-
verted the weakest 5% fluorescence intensities to 0 (back-
ground) and the strongest 5% fluorescence intensities to
1,000 (saturated spots, reflecting normally scanned
images). The other fluorescence intensities were scaled to
the range of 0 to 1,000. This transformation makes differ-
ent slides and different channels comparable. It is similar
to Affymetrix single channel data normalization. The
transformed images and intensities were used for data
quality filters, statistics tests, and direct confirmation of
the data analysis results with spot images.
For spot quality evaluation, a quality index (QI) was
assigned to each spot based on signal intensity and signal-
to-noise ratio. QI 0–4 indicate empty, weak, middle,
strong, and saturated spots, respectively. By default, QI 0
and 4 were assigned to the empty and saturated spots,
whose intensities were less than 30% and greater than
95%, respectively. QI 1–3 was calculated, based on the
intensity of spot signals, as: ,
where QIij is the quality index of spot j on slide i and Iij the
intensity of the spot j on slide i. By default, I0 is the inten-
sity at 30th percentile, and I1 at 95th percentile of the plot
(intensity vs gene rank percentage) of the slide image. A
QI of 5 was assigned to a contaminated or bad spot based
on signal background ratio (SBR). By default, any spots
with a SBR of <2.0 were given a QI of 5. A mean quality
index was calculated from the replicated spots of a gene
from multiple slides, excluding bad spots (QI = 5). Data
were filtered if a mean quality index was 1.0 or less.
For the genes that passed the quality index filter, statistical
tests were performed. The genes with a significantly differ-
ential expression among 6 organs for at least one organ-
pair were identified by a software package, SAM, (Signifi-
cant Analysis of Microarray, http://www-stat.stan
ford.edu/~tibs/SAM/) [11]. The median false discovery
ratio (FDR) cutoff for a multiple class response test by
SAM was set to 5%. The genes with a minimal FDR (q-
value) of >5% were discarded. The genes that passed the
SAM test were further classified into organ-prominent
genes or co-expressed genes in two organs by pair-wise
multiple comparisons with Tukey's honestly significant
difference (HSD) at an overall confidence level of 95%.
Organ-prominent genes were defined as the genes that
were expressed significantly higher in one particular organ
than in other organs (p < 0.05). Similarly, co-expressed
genes in two organs were defined as the genes that were
expressed in the two organs than the other 4 organs.
To determine the relative specificity of a gene among
organs, an organ specificity index (OSI) was defined as the
correlation coefficient of gene expression levels between a
gene and a putative gene. The expression levels of a puta-
tive gene were 1,000 in prominent organs and 0 in other
organs. For example, the expression level of a putative
gene prominent in the lung will be (from left to right are
lung, heart, kidney, liver, spleen, and brain) 1,000, 0, 0, 0,
0, 0. The OSI is calculated as
Where Xi and Pi are the mean gene expression levels of
each organ of a gene and the putative gene, respectively,
in organ i. N is the total number of organs (n = 6 in this
study). A higher correlation coefficient indicates a higher
tendency of a gene for expression in a particular organ.
Finally, the gene expression data were directly compared
with the respective spot images. The spot images of the
genes in each sorted data set were searched and organized
by RealSpot. The genes with visual consistence between
differential gene expression and spot images were marked
as highly prominent genes for the organ(s). The func-
tional categories of these highly prominent genes were
assessed based on gene ontology annotation from Rat
Genome Database gene association file (RGD, http://
rgd.mcw.edu) and gene ontology definitions (GO, http://
www.geneontology.org).
Real-time PCR
Selected lung-specific genes were validated by SYBR Green
I based real-time PCR (QIAGEN, Foster City, CA) as previ-
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scribed into cDNA with 0.2 μg/μl dT17, 0.3 μg/μl random
hexamer primer, and MMLV reverse transcriptase (Invitro-
gen Inc., Carlsbad, CA). The primer pairs were as follows
("_F": forward, "_R": reverse): beta defensin-2, BD-2_F,
AAT CAC ATG CCT GAC CAA AGGA; BD-2_R, GGA GCA
AAT TCT GTT CAT CCCA; keratin19, K19_F, CCA GGT
CGC TGT CCA CAC TAC; K19_R, CCT TCC AGG GCA
GCT TTC AT; vitamin D-dependent calcium-binding pro-
tein, Calb3_F, CAG CAC TCA CTG ACA GCA AGCA,
Calb3_R, TCC TCC TTG GAC AGC TGG TTT; surfactant
protein D, SP-D_F, TTC TCT CCA TGC TTG TCC TGC T,
SP-D_R, GAC TAG GGT GCA CGT GTT GGT T; intercellu-
lar adhesion molecule 1, ICAM-1_F, GGA GTC TCA TGC
CCG TGA AAT, ICAM-1_R, GTG CCT ACC CTC CCA CAA
CA; mitogen activated protein kinase 13, Mapk13_F, CCC
AGC AGC CAT TTG ATG AT, Mapk13_R, CAC TGC AGC
TTC ATC CCA CTT; corticotropin releasing hormone
receptor, Crhr1_F, GGT CTC CAG GGT CGT CTT CAT C,
Crhr1_R, ACG CCA CCT CTT CCG GAT AG; solute carrier
family 29 transporters, member 1, Slc29a1_F, GGA CAA
TGG TCT CTG ACG GAC A; Slc29a1_R, CCT GGA ACA
GGC ACA GAA GAA A; advanced glycosylation end prod-
uct-specific receptor, Ager_F, TCC GGT GTC GGG CAA
CTA, Ager_R, GGG ACA TTG GCT GTG AGT TCAG; solute
carrier family 34 sodium phosphate, member 2,
Slc34a2_F, GCC CAT AGG TGT GAG CCT TTC,
Slc34a2_R, CCC CAT TCA CTC CAT CCT AGG A; lipocalin
2, Lcn2_F, TCT GGG CCT CAA GGA TAA CAAC, Lcn2_R,
AGA CAG GTG GGA CCT GAA CCA; matrix metallopro-
teinase 9, MMP9_F, TGG GCA TTA GGG ACA GAG GAAT,
MMP9_R, GGG CTG TTT CCC CTG TGA GT; nucleoporin
155kd, Nup155_F, AAG TGG ATC AAA ACC GAG TTCG,
Nup155_R, TCG CTG CTG CAG TGA AAT TTC; discoidin
domain receptor family, member 2, Ddr2_F, AAC CAA
GCA CCG ACC ATC CTT, Ddr2_R, ATG TGG CTG AGC
GGT AGG TCT T; trans-acting transcription factor 4,
Sp4_F, TTG TCA CAG TTG CCG CCA TT, Sp4_R, TGA CCA
GCC CAT TTC CAG ATT T; melanoma-associated antigen,
Mg50_F, TGC CAC ATC AGT CAC CCA TGA, Mg50_R,
AGC CGA GAC TCC AGG CTG TTT A;18S rRNA_F: TCC
CAG TAA GTG CGG GTC ATA, 18s rRNA_R: CGA GGG
CCT CAC TAA ACC ATC. The real-time PCR thermal con-
ditions for all 14 genes listed above were 95°C 15 min,
followed by 40 cycles of 95°C for 30 sec, 60°C for 30 sec,
72°C for 30 sec, and 77°C for 35 sec. To eliminate exper-
imental variations, all genes were amplified in the same
plate, each with 6 organ cDNA samples from one rat
(totally 84 wells for organ samples, other wells for nega-
tive controls). Three plates were used for the three biolog-
ical replications. Data were analyzed using relative real-
time PCR quantification based on the delta delta Ct
method [34]. The endogenous reference gene was 18S
rRNA, and the control organ was lung. One-way ANOVA
tests were performed for statistical significance (p < 0.05).
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